Mitchell Levine
2017
In 2017, Mitchell Levine earned a total compensation of $627.7K as Chief Financial Officer at Oncocyte Corp.
Compensation breakdown
| Bonus | $6,864 |
|---|---|
| Option Awards | $578,991 |
| Salary | $41,885 |
| Total | $627,740 |
Levine received $579K in option awards, accounting for 92% of the total pay in 2017.
Levine also received $6.9K in bonus and $41.9K in salary.
Rankings
In 2017, Mitchell Levine's compensation ranked 11,031st out of 14,666 executives tracked by ExecPay. In other words, Levine earned more than 24.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,031 out of 14,666 | 25th |
Division Manufacturing | 4,311 out of 5,768 | 25th |
Major group Chemicals And Allied Products | 1,560 out of 2,074 | 25th |
Industry group Drugs | 1,280 out of 1,730 | 26th |
Industry In Vitro and In Vivo Diagnostic Substances | 50 out of 72 | 31st |
Source: SEC filing on July 27, 2018.
Levine's colleagues
We found three more compensation records of executives who worked with Mitchell Levine at Oncocyte Corp in 2017.